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There is an ongoing debate on the rate and shape of change in outcome variables during the course of
psychotherapy (Baldwin, Berkeljon, Atkins, Olsen, & Nielsen, 2009; Barkham et al., 2006; Kopta,
Howard, Lowry, & Beutler, 1994; Lambert, Hansen, & Finch, 2001; Reese, Toland, & Hopkins, 2011).
The dose–effect model of change was proposed more than 25 years ago by Howard, Kopta, Krause,
and Orlinsky (1986). In their seminal study, they demonstrated a negatively accelerated relationship
between the number of treatment sessions (i.e., dose) and the normalized probability of measurable
client improvement (i.e., effect) using a variety of global outcome variables. For example, after two
sessions, 30% of clients had shown some measurable improvement. This figure increased to 41% after
four sessions, 53% after eight sessions, and 75% after 26 sessions, consistent with a negatively
accelerated dose–effect curve.
Howard et al.’s (1986) study is considered a milestone toward empirically estimating how much
psychotherapy is enough (Kopta, 2003). Specifically, Howard et al. (1986) suggested that 26 sessions—
the dose at which 75% of the clients clearly benefited from treatment—would be a rational limit of the
number of sessions in light of the diminishing cost-effectiveness. However, using a stricter criterion for
clinically significant change, Lambert et al.’s (2001) survival analysis showed that 21 sessions were
necessary for 50% of clients starting within the dysfunctional range to achieve clinically significant
change and that 35 sessions were necessary for 70% of clients. Additional research showed differential
(negatively accelerated) change patterns by diagnosis and symptoms (Barkham et al., 1996; Hansen,
Lambert, & Forman, 2002; Kopta et al., 1994; Maling, Gurtman, & Howard, 1995). Although the specific
number of sessions are often left to administrative purview, monitoring of client progress and
feedback to therapists are often based on comparing clients’ individual progress against negatively
accelerating trajectories (i.e., expected treatment response curves) modeled using a log-linear function
of the session number (e.g., Lambert, 2010; Lambert et al., 2003; Lueger et al., 2001; Lutz, Lambert, et
al., 2006; Lutz, Lowry, Kopta, Einstein, & Howard, 2001; Lutz, Martinovich, & Howard, 1999; Lutz,
Saunders, et al., 2006; Lutz, Stulz, Martinovich, Leon, & Saunders, 2009; Stulz, Lutz, Leach, Lucock, &
Barkham, 2007).
However, criticisms have been raised against Howard et al.’s (1986) and others’ argument for a
negatively accelerating dose–effect curve, as it was modeled using the percentage of clients reaching
pre-to-post treatment improvement as a function of treatment length (i.e., aggregated across clients).
For example, Barkham et al. (1996) reported that session-by-session plots of individual clients’
improvement in time-limited psychotherapies tended to look linear. Further, in their “good enough
level” (GEL) model, Barkham et al. (2006) demonstrated that even with an assumption of linear
change, aggregating data across clients with varying lengths of treatment could misleadingly produce
negatively accelerating aggregate curves, as clients responding more quickly to treatment tend to
terminate earlier. Therefore, to model clients’ trajectory during treatment, data must be modeled
longitudinally rather than cross-sectionally.
To capture clients’ typical patterns of improvement during treatment, progress should ideally be
measured session-by-session using a continuous outcome variable and modeled against the amount of
treatment that the individual clients received (Krause, Howard, & Lutz, 1998). In this study, we used
session-by-session outcome assessments during psychotherapy conducted under routine outpatient

conditions to examine further the relationship between the number of sessions and progress (Krause
et al., 1998). The large database allowed us to examine the pattern of change in client subgroups with
different treatment lengths. Specifically, we addressed the following research questions: (a) Does
individual change on a global clinical symptom scale measured during routine outpatient treatment
follow a linear or a negatively accelerated pattern of change? (b) Does the pattern of change vary
according to treatment duration? (c) Does the rate of change vary according to treatment duration?

Method
Participants
Our sample consisted of 6,375 clients who were treated for at least three sessions at 26 centers, which
included 20 college counseling centers (94% of the clients), four primary care medical centers (5.8%),
and two private mental health centers (0.2%). Data from shorter treatments (one or two sessions)
were excluded as it did not allow for differentiation between linear and negatively accelerated change
in outcome variables during treatment. In addition, clients must have begun treatment in the
dysfunctional range of the measure used, according to the clinical significance cutoff criterion
established by Jacobson and Truax (1991). All clients gave informed consent to allow for their data to
be analyzed in aggregate during the welcome screen message presented to them prior to completing
the electronically administered questionnaire.
The clients were treated between June 2006 and December 2011. All clients were 18 years and older,
and 64% were female. Regarding ethnicity, 62% indicated that they were European American, 7% Asian
American, 6% other, 5% Latino/Hispanic, 5% African American, 1% Native American, 1% Middle
Eastern, and 1% multiracial (13% did not report).

Treatment and Therapists
There were no external criteria for treatment termination; discharge from treatment was at the
therapist’s and client’s discretion. We considered a treatment episode to have ended if there was no
additional treatment session for 3 months or more. If a client had several treatment episodes, only the
first episode was included in the analyses. Treatment durations varied between three and 86 sessions
(M = 8.0, SD = 7.2, Mdn = 5).
Over 500 therapists provided treatment. Most were female (69%) and European American (61%).
Therapists included psychologists, psychiatrists, clinical social workers, and trainees. Most had a
master’s degree (42%) or a doctorate (52%). The therapists varied in professional background and
theoretical orientation, and, although many were familiar with published treatment manuals, they
were not required to follow a manualized treatment protocol. Treatment duration was variable and
not subject to strict time limits, although some therapists set time limits as part of their treatment
strategy.

Measure
The Behavioral Health Measure (BHM; Kopta & Lowry, 2002) is a reliable and valid 21-item self-report
measure that assesses well-being (three items), psychological symptoms (13 items), and life
functioning (four items). An overall suicide risk (one item) appears only when clients indicate self harm
on one of the psychological symptom items. Respondents rate the items regarding how they have been

feeling over the past 2 weeks on a Likert-type scale ranging from 0 (extreme distress/poor functioning)
to 4 (no distress/excellent functioning). The Global Mental Health (GMH) subscale used in this study is
calculated by averaging the 20 items (i.e., excludes the overall suicide risk item). For our analyses, if the
client answered less than 80% of the items, the GMH score was treated as a missing value. A GMH
score below 2.94 indicates that clients are more likely in the clinical population than in the nonclinical
population (Kopta & Lowry, 2002). Analyses have established the internal consistency (Cronbach’s α =
.91) and test–retest reliability (r = .80) of the GMH subscale, as well as its validity (Kopta & Lowry,
2002).

Procedure
Clients were administered the BHM at each psychotherapy session. The instrument was administered
through a computer-based system using an iPad, desktop, or Netbook computer. Clients answered the
items before the session. The therapist then immediately received a clinical report on his or her
computer based on the client’s responses.

Data Analysis
Clients were classified into groups based on the length of the treatment (3, 4, 5, 6, 7, 8, 9, 10, 11–12,
13–14, 15–17, 18–20, 21–25, and 26 or more sessions). We then modeled the pattern of GMH scores
(i.e., the dose–effect relationship) up to Session 20 for each of these groups using latent growth curve
modeling (LGCM; Bollen & Curran, 2006). LGCM enables analysis of longitudinal data by relating an
observed outcome variable (e.g., treatment progress) to time or time-related variables (e.g., number of
treatment sessions). Specifically, individual variation in treatment progress was captured by latent
coefficients on initial severity (i.e., intercept) and trajectory of outcome (i.e., slope for linear or loglinear). Drawing the log of the session number enabled modeling a negatively accelerated relationship
between the number of sessions and treatment progress on the GMH. We thus compared the linear
and log-linear LGCM for every treatment length category. Both the linear and log-linear models were
identical in terms of the number of parameters to estimate.
The fit indices to evaluate the LGCMs (i.e., to see how well a hypothesized model fits the observed
data) included χ2, the comparative fit index (CFI), the Tucker–Lewis index (TLI), the root-mean-square
error of approximation (RMSEA), the standardized root-mean-square residual (SRMR), and the Akaike
information criterion (AIC). As the χ2 test is oversensitive with large samples, most researchers regard
a model as acceptable if the CFI and TLI—which are both based on the χ2 statistic and compare the null
(i.e., uncorrelated) model against the hypothesized model—are greater than 0.9. The RMSEA is a
measure of the discrepancy between the model and the data per degree of freedom, with values closer
to 0 indicating better fit. There is general agreement that a value of less than 0.05 indicates a “good”
fit, and a value of less than 0.08 indicates an “acceptable” fit. The SRMR represents the absolute
difference between the observed and the model-implied correlations with values closer to 0 indicating
better fit; a value of less than 0.10 indicates “acceptable” fit (McDonald & Ho, 2002; Stull, 2008). For
the AIC, no absolute cutoffs are proposed and the model with the smallest AIC is deemed best (Akaike,
1974). Using the Mplussoftware (Version 6.1; Muthén & Muthén, 2010), the LGCMs were estimated
with full information maximum likelihood to handle missing values in outcome variables, which were
assumed to be missing at random (Rubin, 1976; Schafer & Graham, 2002).

Results
The mean GMH score was 2.24 (SD = 0.46) at intake and 2.82 (SD = 0.61) at posttherapy (difference =
0.58; 95% confidence interval = 0.56 to 0.59). The corresponding average pre-post effect size was d =
1.26. Based on Martinovich, Saunders, and Howard’s (1996) reliable change index (RCI; see
also Jacobson & Truax, 1991), the magnitude of the pre-post difference ΔRC that is considered to be
reliable (in the sense of being large enough to be not attributable to measurement error) is calculated
as
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∆𝑅𝑅𝑅𝑅 = 𝑍𝑍𝑅𝑅𝑅𝑅 ∙ �2�𝑆𝑆𝑆𝑆√1 − 𝑟𝑟� = 1.96 ∙ �2�0.47 ∙ √1 − .91� = 0.39.
where zRC is the desired reliability of the change (i.e., 95% two-tailed), SDis the standard deviation of
the GMH score in a community adult sample (Kopta & Lowry, 2002), and r is the reliability (internal
consistency) of the BHM. Of the 6,375 participants in the data set, n = 44 clients did not answer at least
80% of the BHM items at posttreatment and thus were excluded. Of the remaining 6,331 clients, 3,965
(62.6%) clients reliably improved, including 2,657 (42.0%) clients who also achieved clinically significant
improvement (i.e., scored above the GMH cutoff of 2.94 at termination). The proportion of clients who
achieved clinically significant improvement (42.0%) was within the range usually found in clinical trials
(40–70%, Lambert, 2013).
The visual inspection of Figures 1 and 2 suggests that the patterns of GMH mean scores over the first
20 psychotherapy sessions appear negatively accelerated rather than linear irrespective of the
treatment length. Statistical analyses supported this impression, as the log-linear LGCMs consistently
outperformed the linear models on all model fit criteria irrespective of the total amount of treatment
(cf. online Supplement 1).

Figure 1. Dose–outcome relationships for varying treatment durations (three to nine sessions): observed
and estimated global mental health (GMH) mean scores.

Figure 2. Dose–outcome relationships for varying treatment durations (more than nine sessions):
observed and estimated global mental health (GMH) mean scores.
We then examined the development of the percentage of reliably improved clients as a function of the
number of sessions. Although these analyses are subject to loss of information (due to dichotomizing
continuous outcomes into reliably improved or not), they allow us to compare our findings to previous
studies reporting percentage of clients with reliable change (Howard et al., 1986; Lambert et al., 2001).
As can be seen by visual inspection of the Figures in online Supplement 2, treatment progress also

suggests negative acceleration of percentage of clients obtaining reliable change, and this occurred
irrespective of the total amount of treatment.
Our analyses also revealed that faster rates of change were related to shorter treatments (Table 1).
The Spearman rank correlations between the mean rates of change and the categorized treatment
durations were r = –.996 (p < .001) for the slopes derived from linear LGCMs and r = –.974 (p< .001) for
the slopes derived from the log-linear growth models. Table 1furthermore presents the proportion of
clients who achieved clinically significant improvement by the end of therapy stratified by the total
number of sessions attended. The percentage of clients attaining clinically significant improvement
ranged between 32.1% and 63.1%, depending on the duration of treatment (Spearman rank
correlation between percentage attaining clinical significance and the categorized treatment
durations: r = .714; p = .004).

Table 1 Latent Growth Parameters and Clinically Significant Pre-Post-Treatment Improvement
Log-linear
model

Clients
n

M

SD

M

SD

M

SD

M

SD

Clinically
improveda
n

1,517
958
719
505
426
336
301
243
344
237
252
159
163
215

2.231
2.233
2.280
2.361
2.344
2.358
2.387
2.462
2.423
2.424
2.461
2.467
2.529
2.468

0.406
0.404
0.396
0.365
0.434
0.417
0.410
0.392
0.446
0.451
0.411
0.430
0.439
0.453

0.232
0.217
0.137
0.102
0.085
0.078
0.068
0.050
0.046
0.039
0.030
0.028
0.016
0.017

0.235
0.210
0.105
0.089
0.089
0.071
0.055
0.063
0.055
0.045
0.032
0.032
0.032
0.032

2.220
2.225
2.225
2.294
2.247
2.241
2.249
2.317
2.252
2.245
2.312
2.253
2.349
2.300

0.423
0.414
0.406
0.385
0.429
0.391
0.392
0.382
0.422
0.431
0.416
0.417
0.452
0.447

0.970
0.853
0.799
0.678
0.656
0.667
0.659
0.552
0.576
0.539
0.445
0.510
0.356
0.357

0.925
0.802
0.628
0.604
0.622
0.554
0.510
0.528
0.509
0.475
0.415
0.449
0.469
0.396

486
366
299
222
182
168
145
115
176
107
136
99
74
100

Intercept
Treatment
duration
(sessions)
3
4
5
6
7
8
9
10
11–12
13–14
15–17
18–20
21–25
≥26

Linear
model

Slope

Intercept

Slope

significant
%
32.1
38.4
41.8
44.3
43.2
50.1
48.3
47.3
51.9
45.3
54.6
63.1
46.3
48.1

n = 44 clients did not answer at least 80% of the Behavioral Health Measure (Kopta & Lowry, 2002) items at posttreatment. These clients
were excluded from the analyses, as they were not considered to have a valid Global Mental Health score at posttreatment.
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Discussion
Consistent with the dose–effect model (Howard et al., 1986), our results suggest that treatment
responses modeled longitudinally under routine outpatient conditions proceed in a negatively
accelerated manner. Using a global mental health measure, this negatively accelerating curve of
improvement was shown to model treatment progress better than a linear model irrespective of the
length of treatment.
These findings suggest that the negatively accelerating pattern of change is not an artifact of
disregarding the varying treatment lengths and cross-sectionally aggregating the percentage of clients
reaching a criterion for improvement, as was suggested by Barkham et al. (2006). While Barkham et al.
examined time-limited therapies, our findings suggest that, at least in unrestricted therapies, the
average rate of change during psychotherapy can be expected to diminish with each additional session
irrespective of the length of treatment. These results are consistent with previous studies
(e.g., Howard et al., 1986; Kopta et al., 1994), and the results may also corroborate Reese et al.’s
(2011) findings had they retained the (statistically significant) curvilinear parameters in their growth
models. While their argument toward discarding curvilinear trends in favor of parsimony is
understandable, the linear and log-linear LGCMs used in our study were equivalent in model
complexity given that the number of parameters to estimate was identical in both models. Further, as
the negatively accelerated LGCMs were shown to estimate treatment progress consistently better than
linear models, improvement of clients’ distress cannot be expected to be linear in outpatient
psychotherapy. On average, clients appear to experience relatively rapid improvement in early
treatment stages, whereas the effect of treatment seems to decrease in later stages. Our findings are
therefore in line with the dose–effect model.
Our results, however, also corroborate the GEL model (Barkham et al., 2006). Although treatment
progress typically proceeded in a negatively accelerated manner, the rate of change was inversely
related to the total amount of psychotherapy. Consistent with the GEL model, rapid improvement was
associated with shorter treatment duration and vice versa (Baldwin et al., 2009; Barkham et al.,
2006; Reese et al., 2011). This may suggest that clients decide to terminate when they feel that they
have reached an acceptable level of improvement. Concurrently, our findings are at odds
with Barkham et al.’s (2006) in that they found the length of treatment to be negatively related to the
proportion of clinically significant improvement at discharge (r = –.91). Consistent with Baldwin et al.
(2009), we found the rate of clinically significant improved clients to increase with the total number of
sessions attended (r = .71).
Taking these findings together, our study provides support for both the dose–effect and the GEL
models of change in psychotherapy. As proposed by the dose–effect model, the expected course of
improvement in psychotherapy follows a negatively accelerated pattern, irrespective of the duration of
the treatment. However, the dose–effect model must not be understood to imply that the rate of the
negative acceleration is constant across all treatment lengths. Given that the rate of change varies as a
function of treatment duration, we can no longer argue for a consistent relationship between the
expected effect of treatment and number of sessions across clients (e.g., a 75% chance of
improvement after 26 sessions of treatment for every client). The amount of improvement must be
evaluated in light of whether the treatment has concluded or is ongoing. As proposed by the GEL

model, people seem to remain in therapy until they reach a GEL, leading to termination. This level of
improvement, however, is typically reached by a log-linear rather than by a linear and steady pattern
of change.

Limitations
Our study has several limitations. First, the study was based on naturalistic data. While this may
suggest higher external validity, it implies lower internal validity compared to experimentally
controlled studies. The current study shares typical limitations of studies conducted under routine care
conditions, including limited information on clients, diagnoses, therapists, and therapies. An additional
consequence of a naturalistic design is the possibility that there are unobserved variables associated
with treatment progress that were not controlled. In particular, the treatment response curves
presented in this study can be argued as a combination of both the effects of psychotherapy and of
“spontaneous” recovery, as the data do not allow for modeling a nontreatment control group.
However, given that the majority of controlled studies have shown that psychotherapy is far superior
to spontaneous recovery (Lambert, 2013) and in light of the observed absolute pre-post treatment
effect size, we believe that what was modeled using this data reflects actual treatment progress.
Another potential limitation is that we chose the number of sessions as the dose of treatment to
determine the dose–effect relationship. The underlying assumption is that the number of sessions is
related to the amount of exposure to the active ingredients in psychotherapy (Howard et al., 1986).
Although some findings suggest that the time between sessions (i.e., session frequency) is also related
to the rate of change (Reese et al., 2011), it is unlikely that session frequency would affect the
trajectory of change (i.e., negative acceleration) even if it may contribute to interindividual variability
in growth rates.
Third, our analyses are limited to the first 20 sessions of treatment. Thus, there is no evidence that our
findings generalize to treatments beyond 20 sessions.
Fourth, our clients were treated at different types of centers (college counseling centers, primary care
medical centers, and private mental health centers), and not all of them had complete session-bysession outcome data. However, the majority of the clients in our sample were treated at university
counseling centers (94%) and most of the clients had no missing data points (97%). Thus, it is unlikely
that our findings were affected by missing data or by varying types of treatment centers. When
rerunning the LGCM analyses for the subsample of those 5,836 (92%) clients who were treated at
university counseling centers and who had no missing values in the outcome variables, the log-linear
LGCMs again consistently outperformed the linear models irrespective of treatment duration.
Fifth, therapists were provided regular feedback regarding their clients’ BHM scores. Thus, our findings
may not generalize to settings where no feedback is given to therapists. As Lambert and others
(e.g., Lambert, 2010) have shown, feedback to therapists over the course of treatment tends to
improve the outcomes of clients.
Sixth, we used a single, client-reported general clinical symptom measure as the outcome variable.
Whether our findings generalize to different measures, domains, and perspectives remains an
empirical issue.

Last, it is important to note that while the log-linear growth models explained change in outcome
consistently better than the linear models, both types of models are nevertheless aggregated
approximations of treatment progress. As individual client’s progress varies substantially from the
average course of treatment, these models should not be considered trajectories that every client
should follow. Research has shown that large between-session changes occur during the course of
treatment (so-called “sudden gains” and “sudden losses”; e.g., Tang & DeRubeis, 1999). Thus, not
surprisingly, the proportion of unexplained variance is considerably large even when modeled with loglinear LGCMs, especially for longer treatments. Nevertheless, we believe that modeling the negatively
accelerating rate of change has benefits over and above linear models in predicting treatment
progress.

Implications
These findings have important implications for psychotherapy research, practice, and policy. Consistent
with previous research, our results suggest that client-focused research should model the course of
treatment assuming a negatively accelerating rather than a linear rate of change (Lueger, Lutz, &
Howard, 2000; Lutz et al., 2001; Lutz et al., 1999; Stulz, Gallop, Lutz, Wrenn, & Crits-Christoph,
2010; Stulz & Lutz, 2007; Stulz et al., 2007).
For clinicians, it is important to bear in mind that the impact of each session may diminish as treatment
length increases. While the rate of change may differ considerably across clients and is typically related
to the total number of sessions that the client attends, on an intraindividual level, a negatively
accelerating rate of improvement may be expected. However, this does not mean that treatments
should be brief. When the curve starts accelerating more slowly, this does not necessarily indicate
termination or that clients will not improve with more treatment, as the percentage of clinically
significant improvement was shown to increase with the total number of sessions attended.
Furthermore, our data indicate considerable variability with the clients’ individual slopes, particularly
for those terminating treatments early. Some clients may have terminated early because they felt
better, whereas others may have terminated early because therapy was not working well or for other
reasons.
Policy makers should be aware that there is no prespecified dose of therapy that could be
recommended across all clients. Despite the recent surge of time-limited psychotherapy, these session
limits have been determined arbitrarily. To achieve optimal treatment outcomes from the perspectives
of both individual clients and organizations (e.g., third-party payers), resource allocation should be
based not on a predetermined number of sessions that a particular client should be offered but rather
on the client’s actual degree of improvement based on psychometric progress monitoring.
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